愛污传媒

Skip to main content

J&J suspends COVID-19 vaccine sales forecast

Share

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

A global supply surplus and uncertainty about future demand -- fueled in part by vaccine hesitancy in some developing markets -- prompted the change, J&J said Tuesday. The company also reported a better-than-expected first-quarter profit and announced a dividend increase.

J&J's one-shot vaccine brought in $457 million in global sales during the first quarter, while the company's pharmaceutical sales as a whole totaled nearly $13 billion.

The vaccine registered only $75 million in sales in the U.S., or about 25% less than what it rang up after debuting in last year's first quarter.

J&J has said it doesn't intend to profit from the vaccine. But it said in January that the shot could bring in between $3 billion and $3.5 billion in sales this year, as countries continue to fight variants of the virus.

Demand for initial vaccine doses and booster shots has slowed since shots from J&J, Pfizer and Moderna entered the U.S. market last year. More than 82% of the U.S. population age 5 and older has already received at least one vaccination dose, according to the Centers for Disease Control and Prevention.

Options from Pfizer and Moderna also have been much more commonly used in the United States.

U.S. regulators also have said that most Americans should receive the Pfizer or Moderna shots instead of J&J's version due to a rare blood clotting problem tied to the shot.

Vaccine sales are a small part of the total revenue picture for Johnson & Johnson. The company also sells medical devices, consumer health products like Band-Aids and a range of pharmaceuticals. That includes the cancer treatment Darzalex, which brought in $1.86 billion in the quarter.

Overall, J&J's profit fell 17% to $5.15 billion in the first quarter, as research and development costs and other expenses climbed. Adjusted earnings came to $2.67 per share, as total revenue grew 5% to $23.4 billion.

Analysts expected, on average, earnings of $2.58 per share on $23.62 billion in revenue.

J&J said Tuesday that it now expects 2022 adjusted earnings of $10.15 to $10.35 per share, a drop from its previous forecast that company officials attributed to foreign currency rate changes.

Wall Street expects, on average, earnings of $10.55 per share.

Separately, the company said Tuesday that it was raising the quarterly dividend it pays shareholders by 7 cents to $1.13 per share. That will hike the annual payout to $4.52 per share from $4.24.

Shares of New Brunswick, New Jersey-based Johnson & Johnson, which is a component of the Dow Jones Industrial Average, climbed 3% to $183.03 in late-morning trading.

The Dow was up around 1%.

CTVNews.ca Top Stories

A whirlwind 28-day campaign has now ended, undoubtedly going down in history one of the most unusual election campaigns British Columbians have ever seen.

A number of parents at Oyster Pond Academy pulled their children from class Friday after learning about a gender identity presentation.

A Waterloo, Ont. man is sharing video of a recent encounter with a stranger to give others an idea of the hate he experiences in the community.

If you're heading out trick or treating this Halloween, you may end up with more chips, gummies, licorice and other goodies rather than chocolate. Cocoa prices have spiked, and that could be playing a trick with what your kids come home with and what you give out on Halloween night.

愛污传媒 Vancouver will have special coverage of B.C.鈥檚 43rd general election on Saturday evening, with live results and analysis.

Local Spotlight

The image of a sleepy Saskatchewan small town with 'not a lot going on' is a well-known anecdote. However, one Saskatchewan company is hoping to change that 鈥 and allow communities both on and off the beaten path to share their stories and advertise what they have to offer.

A Moncton, N.B., home has been donated to the Friends of The Moncton Hospital Foundation and will be transformed into a resource hub for people living with cancer.

A Nova Scotia man crossing Canada on foot is passing through southwestern Ontario. Trevor Redmond is perhaps better known as the 鈥楩ellow in Yellow.鈥

John Cantin vividly remembers opening day for his Victoria diner. Stress levels were high, tables were full, and one of the most popular menu items couldn鈥檛 be freed from the unyielding grip of the waffle maker.

A Manitoba professor is warning the public after a book on regional mushrooms that he suspects is AI-generated was delisted from Amazon.

A B.C. judge has issued a decision in a years-long dispute between neighbours that began with a noise complaint over barking dogs, crowing roosters and quacking ducks 鈥 awarding $15,000 in damages to the plaintiffs in the case.

An Ottawa man was arrested after taking a shower in a stranger's house, Ottawa police say.

S岣祑x瘫w煤7mesh 脷xwumixw (Squamish Nation) Chef Paul Natrall, the man behind Indigenous food truck Mr. Bannock, is bringing cooking classes on First Nations fare to schools and offices throughout Metro Vancouver.

The Celtic Colours Festival is taking place at venues around Cape Breton Island in Nova Scotia from Oct. 11 to 19.

Stay Connected